Magnetic Resonance Imaging Techniques for Post-Treatment Evaluation After External Beam Radiation Therapy of Prostate Cancer: Narrative Review.

IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL

Clinics and Practice Pub Date : 2024-12-27 DOI:10.3390/clinpract15010004

Eleni Bekou, Admir Mulita, Ioannis Seimenis, Athanasia Kotini, Nikolaos Courcoutsakis, Michael I Koukourakis, Francesk Mulita, Efstratios Karavasilis

{"title":"Magnetic Resonance Imaging Techniques for Post-Treatment Evaluation After External Beam Radiation Therapy of Prostate Cancer: Narrative Review.","authors":"Eleni Bekou, Admir Mulita, Ioannis Seimenis, Athanasia Kotini, Nikolaos Courcoutsakis, Michael I Koukourakis, Francesk Mulita, Efstratios Karavasilis","doi":"10.3390/clinpract15010004","DOIUrl":null,"url":null,"abstract":"Background/Objectives: This study aimed to investigate the prognostic value of advanced techniques of magnetic resonance imaging (MRI) biochemical recurrence (BCR) after radiotherapy in patients with prostate cancer (PCa). Methods: A comprehensive literature review was conducted to evaluate the role of MRI in detecting BCR of PCa patients after external beam radiation therapy. Results: National guidelines do not recommend imaging techniques in clinical follow-up PCa. However, in 2021, the European Association of Urogenital Radiology (ESUR), the European Association of Urological Imaging (ESUI), and the PI-RADS Steering Committee introduced the Prostate Imaging for Recurrence Reporting (PI-RR) system. PI-RR incorporates the MRI biomarkers in the post-treatment process. In the last decade, a growing number of clinical researchers have investigated the role of various MRI techniques in BCR. Conclusions: The integration of advanced MRI technologies into clinical routine marks the beginning of a new era of BCR with accuracy.","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 1","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763658/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/clinpract15010004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background/Objectives: This study aimed to investigate the prognostic value of advanced techniques of magnetic resonance imaging (MRI) biochemical recurrence (BCR) after radiotherapy in patients with prostate cancer (PCa). Methods: A comprehensive literature review was conducted to evaluate the role of MRI in detecting BCR of PCa patients after external beam radiation therapy. Results: National guidelines do not recommend imaging techniques in clinical follow-up PCa. However, in 2021, the European Association of Urogenital Radiology (ESUR), the European Association of Urological Imaging (ESUI), and the PI-RADS Steering Committee introduced the Prostate Imaging for Recurrence Reporting (PI-RR) system. PI-RR incorporates the MRI biomarkers in the post-treatment process. In the last decade, a growing number of clinical researchers have investigated the role of various MRI techniques in BCR. Conclusions: The integration of advanced MRI technologies into clinical routine marks the beginning of a new era of BCR with accuracy.

查看原文本刊更多论文

背景/目的：本研究旨在探讨磁共振成像（MRI）先进技术对前列腺癌（PCa）患者放疗后生化复发（BCR）的预后价值。方法：对文献进行全面回顾，评估磁共振成像在检测PCa患者外照射治疗后生化复发（BCR）方面的作用。结果：国家指南并未推荐在 PCa 临床随访中使用成像技术。但在 2021 年，欧洲泌尿放射协会（ESUR）、欧洲泌尿成像协会（ESUI）和 PI-RADS 指导委员会推出了前列腺成像复发报告（PI-RR）系统。PI-RR 将核磁共振成像生物标志物纳入治疗后流程。近十年来，越来越多的临床研究人员对各种磁共振成像技术在前列腺癌复发中的作用进行了研究。结论：将先进的磁共振成像技术纳入临床常规标志着精确 BCR 新时代的开始。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊